Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

Wednesday, May 08 2024
08:00 AM – 09:45 AM ET
Ballroom 4

From the Clinic Back to the Bench: Solving Old Problems with New Technologies (Organized by the Neurologic and Ophthalmic Gene and Cell Therapy Committee)

This session will focus on the learnings acquired based on the post-approval experience of physicians using Luxturna and Zolgesma in their clinical practice, highlighting the successes and limitations of these two products. It will be followed by an overview of “what is next to treat neurological and ophthalmic disorders”. An expert panel will discuss novel viral and cell technologies that are currently  being developed to overcome some of the limitations encountered by the current therapies.

Session Details

08:00 AM - 09:45 AM - Ballroom 4

Eva Andres-Mateos - PhD - Atsena Therapeutics

Co-Chair

08:00 AM - 09:45 AM - Ballroom 4

Heather Gray-Edwards - DVM, PhD - UMass Chan Medical School

Co-Chair

08:00 AM - 08:26 AM - Ballroom 4

Christine Kay - Vitreoretinal Associates

Optimizing subretinal Gene therapy: surgical techniques and capsid design

08:26 AM - 08:52 AM - Ballroom 4

Kevin Strauss - MD - Clinic for Special Children

Post-approval experience in clinical implementation for CNS gene therapies

08:52 AM - 09:18 AM - Ballroom 4

Yuija Cai - PhD - Shanghai Jiao Tong University

Beyond AAV, Gene Editing of HSV in Patients with herpetic stromal keratitis

09:19 AM - 09:45 AM - Ballroom 4

Stephanie Cherqui - PhD - University of California, San Diego

From cystinosis to Friedreich’s ataxia and Alzheimer’s disease: Lessons learned from a rare metabolic disease using ex vivo gene therapy

© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.